[go: up one dir, main page]

NO993670L - Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS - Google Patents

Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS

Info

Publication number
NO993670L
NO993670L NO993670A NO993670A NO993670L NO 993670 L NO993670 L NO 993670L NO 993670 A NO993670 A NO 993670A NO 993670 A NO993670 A NO 993670A NO 993670 L NO993670 L NO 993670L
Authority
NO
Norway
Prior art keywords
aids
drugs
inhibitors
treatment
reverse transcriptase
Prior art date
Application number
NO993670A
Other languages
English (en)
Other versions
NO993670D0 (no
Inventor
Arnold Paessens
Martin Blunck
Guenter Riess
Joerg-Peter Kleim
Manfred Roesner
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO993670D0 publication Critical patent/NO993670D0/no
Publication of NO993670L publication Critical patent/NO993670L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse vedrører anvendelse av quinoksaliner i en trippelkombina- sjon med proteaseinhibitorer og reverstranskriptaseinhibitorer som medikamenter for behandling av AIDS- og/eller HIV-infeksjoner.
NO993670A 1997-01-29 1999-07-28 Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS NO993670L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (de) 1997-01-29 1997-01-29 Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
PCT/EP1998/000197 WO1998032442A1 (de) 1997-01-29 1998-01-15 Chinoxaline in dreier-kombination mit proteaseinhibitoren und reverse transkriptaseinhibitoren als arzneimittel zur behandlung von aids

Publications (2)

Publication Number Publication Date
NO993670D0 NO993670D0 (no) 1999-07-28
NO993670L true NO993670L (no) 1999-09-10

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993670A NO993670L (no) 1997-01-29 1999-07-28 Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS

Country Status (16)

Country Link
EP (1) EP0977570A1 (no)
JP (1) JP2001511124A (no)
KR (1) KR20000070543A (no)
CN (1) CN1251525A (no)
AR (1) AR011094A1 (no)
AU (1) AU6094098A (no)
BR (1) BR9807523A (no)
CA (1) CA2278773A1 (no)
DE (1) DE19703131A1 (no)
ID (1) ID22414A (no)
IL (1) IL130877A0 (no)
NO (1) NO993670L (no)
PL (1) PL334770A1 (no)
SK (1) SK99899A3 (no)
WO (1) WO1998032442A1 (no)
ZA (1) ZA98679B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
WO2000018384A2 (en) * 1998-09-28 2000-04-06 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2h-quinoxaline-1-carboxylic acid isopropyl ester and amprenavir
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (es) 2001-03-19 2004-05-05 Astrazeneca Ab Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CA2633400A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0509398B1 (de) * 1991-04-15 2001-09-19 Aventis Pharma Deutschland GmbH Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen

Also Published As

Publication number Publication date
ZA98679B (en) 1998-08-05
JP2001511124A (ja) 2001-08-07
IL130877A0 (en) 2001-01-28
CN1251525A (zh) 2000-04-26
NO993670D0 (no) 1999-07-28
AU6094098A (en) 1998-08-18
AR011094A1 (es) 2000-08-02
SK99899A3 (en) 2000-03-13
WO1998032442A1 (de) 1998-07-30
EP0977570A1 (de) 2000-02-09
BR9807523A (pt) 2000-03-21
PL334770A1 (en) 2000-03-13
CA2278773A1 (en) 1998-07-30
DE19703131A1 (de) 1998-07-30
ID22414A (id) 1999-10-14
KR20000070543A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
NO993670L (no) Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS
BR0309557A (pt) Inibidores da transcriptase reversa não nucleosìdeos
TR200002759T2 (tr) Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı.
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
TR200101400T2 (tr) 2-Fenilbenzimidazoller ve 2-fenilindoller, hazırlanmaları ve kullanımları
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
TR200103216T2 (tr) Pirimidinon bileşimleri
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
ME00578A (en) Use of gastrointestinal lipase inhibitors
FI923158A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoidossa
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
ATE277943T1 (de) Trypsininhibitoren
HUP9901642A2 (hu) Szerek AIDS kezelésére és megelőzésére
BRPI0513051A (pt) combinação de inibidores de transcriptase reversa e de protease anti-hiv
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
DE69332904D1 (de) Hemmung von hiv-infektion
ES2190456T3 (es) Combinacion de inhibidores de la proteasa del vih.
NO20040561L (no) Behandling av lipodystrofi
DK1032407T3 (da) Anvendelse af putamen ovi
ECSP961660A (es) Terapia combinada para infeccion por vih
KR960021044A (ko) 세코노가노사이드를 포함하는 b형 간염 치료제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application